Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul Gerard Guy Richardson, M.B.,B.S.


This page shows the publications co-authored by Paul Richardson and Omar Nadeem.
Connection Strength

  1. The initial management of multiple myeloma in the era of novel agents: 2021 and beyond. Br J Haematol. 2021 04; 193(2):213-215.
    View in: PubMed
    Score: 0.952
  2. Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. Br J Haematol. 2021 Oct 21.
    View in: PubMed
    Score: 0.248
  3. A clinical perspective on plasma cell leukemia; current status and future directions. Blood Cancer J. 2021 02 04; 11(2):23.
    View in: PubMed
    Score: 0.236
  4. Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma. J Clin Oncol. 2021 03 01; 39(7):757-767.
    View in: PubMed
    Score: 0.233
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.